Atossa Therapeutics
ATOS
#10507
Rank
โ‚น2.27 B
Marketcap
โ‚น227.86
Share price
-2.07%
Change (1 day)
196.22%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -โ‚น3.38 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น3.36 Billion a decrease over its 2024 earnings that were of -โ‚น2.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น3.38 Billion0.46%
2025 -โ‚น3.36 Billion36.33%
2024 -โ‚น2.47 Billion-15.25%
2023 -โ‚น2.91 Billion11.62%
2022 -โ‚น2.61 Billion30.84%
2021 -โ‚น1.99 Billion15.58%
2020 -โ‚น1.73 Billion3.41%
2019 -โ‚น1.67 Billion51.16%
2018 -โ‚น1.11 Billion40.41%
2017 -โ‚น0.79 Billion27.54%
2016 -โ‚น0.62 Billion-47.49%
2015 -โ‚น1.18 Billion-17.25%
2014 -โ‚น1.42 Billion35.91%
2013 -โ‚น1.05 Billion112.3%
2012 -โ‚น0.5 Billion46.53%
2011 -โ‚น0.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.508 T-69,117.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น132.85 B-3,755.59%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น132.77 B-3,753.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น4.02 B-210.73%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น9.61 Billion 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น0.76 Billion-79.17%๐Ÿ‡บ๐Ÿ‡ธ USA